The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
Charles River expanded the Memphis facility in November 2022, adding nine processing suites to its 16 clean rooms at the site ...
Shares of US clinical-stage biotech Allogene Therapeutics rocketed 41% to $1.99 on Friday, as it announced the publication of ...
Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.
Hosted on MSN3d
Is stem cell therapy effective for hair growth?Losing around 50 to 100 hair strands in a day should not get you overly concerned. However, seeing more scalp than hair is ...
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...
The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.
Inc. and acquired a worldwide license to Precision's Azercabtagene Zapreleucel (azer-cel), an investigational allogeneic or "off the shelf" CD19 CAR T cell therapy program for autoimmune diseases ...
Patients with childhood and young adult cancer have an increased long-term risk for diabetes, noted as early as 10 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback